Dr. Alexandra Rezazadeh, MD
- Medicare services, 2024
- 139
- Medicare patients, 2024
- 64
- Part D claims, 2024
- 736
- Publications
- 6
- MIPS score, 2024
- 93
- Practice address
- 701 Park Avenue, Minneapolis, MN 55415
- Practice phone
- Call (612) 873-3000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Rezazadeh's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Alexandra Rezazadeh is a medical oncologist in Minneapolis, Minnesota
Dr. Rezazadeh practices at Hennepin County Medical Center in Minneapolis, Minnesota, part of Hennepin County.
Dr. Rezazadeh's NPI, 1053843573, was assigned on April 3, 2017. Dr. Rezazadeh graduated from University of Wisconsin School of Medicine in 2017. Dr. Rezazadeh holds Minnesota license 75037.
- NPI
- 1053843573NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6608205216
- NPI enumeration date
- April 3, 2017
- NPI status
- Active
- Practice phone
- (612) 873-3000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 35
- Medical school graduation
- 2017
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Alexandra Rezazadeh practices at Hennepin County Medical Center in Minneapolis, Minnesota
Dr. Rezazadeh's primary practice is Hennepin County Medical Center, at 701 Park Avenue, Minneapolis, MN 55415 in Hennepin County. The practice phone is (612) 873-3000.
- Hennepin County Medical Center701 Park Avenue, Minneapolis, MN 55415 · Hennepin CountyPhone(612) 873-3000
Source: Dmand AI Affiliation Data
Dr. Alexandra Rezazadeh is affiliated with 1 site of care and 1 medical group
Dr. Rezazadeh's primary practice is Hennepin County Medical Center in Minneapolis, Minnesota, part of Hennepin County. The medical group on file is Hennepin Healthcare. Dr. Rezazadeh's employer is on file too: a hospital.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Alexandra Rezazadeh's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rezazadeh practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Hennepin County Medical Center | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Hennepin County and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Alexandra Rezazadeh is one of 122 medical oncologists in Minnesota
Medical oncology is Dr. Rezazadeh's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Rezazadeh is licensed in Minnesota.
Specialties and state licenses
- Medical oncology, MinnesotaPrimary
Medical oncologists near Dr. Rezazadeh
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Alexandra Rezazadeh billed Medicare for 139 services in 2024
CMS data shows 139 Medicare services from Dr. Rezazadeh across 2 procedure codes in 2024, all of them office visits, for 64 Medicare patients. Medicare paid $12,519 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Rezazadeh's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 252024: 139456%
Dr. Rezazadeh compared with the Minnesota median for medical oncologists, 2024
- Dr. Rezazadeh
- Minnesota median
- Medicare services
- 139vs 1,28489% below
- Medicare patients
- 64vs 24874% below
- Part D claims
- 484vs 1962.5 times
Medians across 119 medical oncologists in Minnesota with Dmand AI profiles that report each measure.
Dr. Rezazadeh's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Rezazadeh?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Rezazadeh and other medical oncologists in Minnesota.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Alexandra Rezazadeh treated 64 Medicare patients in 2024, average age 69
CMS counts 64 Medicare patients who saw Dr. Rezazadeh in 2024. The largest group is under 65, with 23 patients. 69% of them have high blood pressure, and 52% have cancer. 66% are also on Medicaid. Their average risk score is 3.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Rezazadeh's median patient age at 62, with 51% women.
Dr. Rezazadeh's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Rezazadeh's Medicare patients by sex, 2024
- Women2945%
- Men3555%
Chronic conditions among Dr. Rezazadeh's Medicare patients, 2024
- High blood pressure69%
- Cancer52%
- High cholesterol45%
- Diabetes39%
- Chronic kidney disease34%
- Tobacco use34%
- Anxiety31%
- Arthritis30%
Share of Medicare patients with each condition. A patient can have several.
Dr. Rezazadeh's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 62
Patient panel by sex, all payers
- Women51%
- Men49%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Alexandra Rezazadeh wrote 736 Medicare Part D claims in 2024
In 2024, Dr. Rezazadeh wrote 736 Medicare Part D claims for 98 patients. 84% of them were for generic drugs. CMS names the drug for 484 of them, across 18 drugs with 11 or more claims each, at $281,075 in total drug cost. In 2023, CMS named 15 claims across 1 drug.
Dr. Rezazadeh's Part D claims by kind of drug, 2024
- Generic618 claims84%
- Brand-name118 claims16%
Dr. Rezazadeh's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Rezazadeh's Part D claims, 2024
- Opioids13%93 of 736 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 152024: 4843127%
Drugs named by CMS: 18 in 2024, 1 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Alexandra Rezazadeh scored 93 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Rezazadeh for performance year 2024, reported as part of a group.
Dr. Rezazadeh's MIPS scores, performance year 2024
- 93of 100Final score
- 74.5of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 73of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Alexandra Rezazadeh has 6 publications on record
Dmand AI links 6 papers to Dr. Rezazadeh, published from 2020 to 2024. 2023 was the busiest year, with 2. Dr. Rezazadeh's most frequent co-authors are Ehab L. Atallah, MD, Timothy S. Fenske, MD and Sameem M. Abedin, MD.
Dr. Rezazadeh's papers by year, 2020 to 2024
Dr. Rezazadeh's most frequent co-authors
- Ehab L. Atallah, MD3 shared papers
- Timothy S. Fenske, MD2 shared papers
- Sameem M. Abedin, MD1 shared paper
Recent publications by Dr. Rezazadeh
Clin Lymphoma Myeloma Leuk
Curr Treat Options Oncol
See who Dr. Rezazadeh researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Rezazadeh works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Alexandra Rezazadeh received $2,904 in industry payments from 2021 to 2025
CMS Open Payments shows 27 general payments to Dr. Rezazadeh from 16 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 95% of the total. AstraZeneca Pharmaceuticals LP paid the most, $539.
General payments to Dr. Rezazadeh by program year, 2021 to 2025
General payments to Dr. Rezazadeh by kind, 2021 to 2025
- Food and beverage$2,76095%
- Education$1435%
Companies that paid Dr. Rezazadeh the most, 2021 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Alexandra Rezazadeh graduated from University of Wisconsin School of Medicine
Dr. Rezazadeh graduated from University of Wisconsin School of Medicine in 2017.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Alexandra Rezazadeh's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Alexandra Rezazadeh
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Alexandra Rezazadeh's NPI number?
Dr. Alexandra Rezazadeh's NPI number is 1053843573. It was assigned on April 3, 2017, and it is active in the NPI Registry.
What kind of doctor is Dr. Alexandra Rezazadeh?
Dr. Alexandra Rezazadeh is a medical oncologist in Minneapolis, Minnesota. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Alexandra Rezazadeh practice?
Dr. Rezazadeh practices at 701 Park Avenue, Minneapolis, MN 55415. Dr. Rezazadeh's primary practice is Hennepin County Medical Center in Minneapolis, Minnesota, part of Hennepin County.
What is Dr. Alexandra Rezazadeh's office phone number?
The practice phone on file for Dr. Rezazadeh is (612) 873-3000.
What is Dr. Alexandra Rezazadeh's medical license number?
Dr. Rezazadeh holds Minnesota license 75037.
Which hospitals is Dr. Alexandra Rezazadeh affiliated with?
Dr. Rezazadeh practices at Hennepin County Medical Center in Minneapolis, Minnesota.
What medical group is Dr. Alexandra Rezazadeh part of?
Dr. Rezazadeh is linked to Hennepin Healthcare.
Does Dr. Alexandra Rezazadeh accept Medicare?
Yes. CMS data shows Dr. Rezazadeh billed Medicare for 139 services in 2024.
What is Dr. Alexandra Rezazadeh's MIPS score?
Dr. Rezazadeh's MIPS final score for performance year 2024 is 93 out of 100, reported as part of a group.
How many Medicare patients does Dr. Alexandra Rezazadeh see?
CMS counts 64 Medicare patients who saw Dr. Rezazadeh in 2024, with an average age of 69.
Show 7 more questionsShow fewer questions
What services does Dr. Alexandra Rezazadeh bill to Medicare?
In 2024, Dr. Rezazadeh's most billed Medicare services were office visit, established patient (99215) and office visit, established patient (99214).
Where did Dr. Alexandra Rezazadeh go to medical school?
Dr. Rezazadeh graduated from University of Wisconsin School of Medicine in 2017.
What drugs does Dr. Alexandra Rezazadeh prescribe most?
In 2024 Medicare Part D data, Dr. Rezazadeh's most prescribed drugs by claims were Dexamethasone, Oxycodone HCl and Prochlorperazine Maleate.
Has Dr. Alexandra Rezazadeh received payments from drug or device companies?
CMS Open Payments shows $2,904 in general payments to Dr. Rezazadeh from 16 companies from 2021 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Alexandra Rezazadeh been practicing?
Dr. Rezazadeh graduated from medical school in 2017, 9 years ago.
Does Dr. Alexandra Rezazadeh do research?
Dmand AI links 6 publications to Dr. Rezazadeh, published from 2020 to 2024.
Who does Dr. Alexandra Rezazadeh publish with?
Dr. Rezazadeh's most frequent co-authors are Ehab L. Atallah, MD (3 shared papers), Timothy S. Fenske, MD (2 shared papers) and Sameem M. Abedin, MD (1 shared paper).
Selling to medical oncology practices?
See medical oncologists in Minnesota by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card